An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)
NCT02856802
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
107
Enrollment
INDUSTRY
Sponsor class
Conditions
Migraine Headaches
Interventions
DRUG:
Sumatriptan 10 mg Nasal Spray
OTHER:
Sumatriptan Placebo Nasal Spray
Sponsor
Upsher-Smith Laboratories